First Bank & Trust’s Novo Nordisk NVO Stock Holding History

First Bank & Trust’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-222	Closed	-$12K	–	395
2022 Q2	$12K	Hold	222	–	–	﹤0.01%	333
2022 Q1	$12K	Hold	222	–	–	﹤0.01%	336
2021 Q4	$12K	Buy	222 +50	+29%	+$2.71K	0.01%	340
2021 Q3	$8K	Hold	172	–	–	﹤0.01%	352
2021 Q2	$7K	Hold	172	–	–	﹤0.01%	350
2021 Q1	$6K	Hold	172	–	–	﹤0.01%	357
2020 Q4	$6K	Hold	172	–	–	﹤0.01%	346
2020 Q3	$6K	Hold	172	–	–	﹤0.01%	330
2020 Q2	$6K	Hold	172	–	–	﹤0.01%	323
2020 Q1	$5K	Hold	172	–	–	﹤0.01%	336
2019 Q4	$5K	Hold	172	–	–	﹤0.01%	344
2019 Q3	$4K	Hold	172	–	–	﹤0.01%	344
2019 Q2	$4K	Buy	+172	New	+$4.25K	﹤0.01%	342

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

First Bank & Trust's NVO Position: Q3 2022 in Review

First Bank & Trust sold out of Novo Nordisk (NVO) in Q3 2022, closing a stake of 222 shares — an estimated $12K sold.

First Bank & Trust first reported a position in NVO in Q2 2019 and held it in 13 quarters. The position peaked at $12K in Q2 2022. 907 funds tracked by Wall St. Rank hold NVO as of Q3 2022.

First Bank & Trust reported no remaining Novo Nordisk position as of Q3 2022 after selling out during the quarter.
First Bank & Trust sold 222 Novo Nordisk shares in Q3 2022, an estimated $12K.
First Bank & Trust first reported a position in Novo Nordisk in Q2 2019 and held it in 13 quarters.
First Bank & Trust's Novo Nordisk position peaked at $12K in Q2 2022.
907 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2022.

Based on First Bank & Trust's 13F filing for Q3 2022, filed 28 Oct 2022.